EyePoint Pharmaceuticals (NASDAQ: EYPT)
EyePoint Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
EyePoint Pharmaceuticals Company Info
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
News & Analysis
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
The company reported positive trial data for its lead therapy to treat two different eye conditions.
Why EyePoint Pharmaceuticals Shot 31% Higher Today
The eyecare specialist has good momentum behind it as it prices a new round of capital raising.
Why EyePoint Pharmaceuticals Is Cratering Today
EyePoint's stock offering isn't sitting well with shareholders today. Here's why.
3 Top Small-Cap Stocks to Buy in October
These small-cap healthcare stocks are definitely worth checking out this month.
3 Top Biotech Stocks to Buy in September
These three biotech stocks could be great buys this month.
Keep Your Eye on These 4 Healthcare Stocks
The growing eye industry is something investors can’t ignore.
Here's Why EyePoint Pharmaceuticals Saw Its Share Price Drop Today
A secondary offering raised some cash but diluted current shareholders.
These 2 Biotechs Got Crushed
Highlighting the day's health-care stories critical to investors.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.